BAGE5
gene geneOn this page
Also known as CT2.5
Summary
BAGE5 (BAGE family member 5, HGNC:15732) is a protein-coding gene on chromosome 13cen GRCh38 patch, encoding B melanoma antigen 5 (Q86Y27). Unknown.
Predicted to be located in extracellular region.
Source: NCBI Gene 85316 — RefSeq curated summary.
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:15732 |
| Approved symbol | BAGE5 |
| Name | BAGE family member 5 |
| Location | 13cen GRCh38 patch |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | CT2.5 |
| Entrez | 85316 |
Gene structure
Transcript identifiers
Ensembl transcripts: 0
RefSeq mRNA: 0 — MANE Select: None
Canonical transcript exons
None — 0 exons
Expression profiles
Top tissues by expression
0 total, by Bgee expression score (0-100, higher = more expressed):
Regulation
Is transcription factor: no
Cross-species orthologs
0 orthologs
Protein
Protein identifiers
B melanoma antigen 5 — Q86Y27 (reviewed: Q86Y27)
Alternative names: Cancer/testis antigen 2.5
All UniProt accessions (0):
UniProt curated annotations — full annotation on UniProt →
Function. Unknown. Candidate gene encoding tumor antigens.
Subcellular location. Secreted.
Tissue specificity. Not expressed in normal tissues except in testis. Expressed in melanoma, bladder and lung carcinomas.
Miscellaneous. The ancestral BAGE gene was generated by juxtacentromeric reshuffling of the KMT2C/MLL3 gene. The BAGE family was expanded by juxtacentromeric movement and/or acrocentric exchanges. BAGE family is composed of expressed genes that map to the juxtacentromeric regions of chromosomes 13 and 21 and of unexpressed gene fragments that scattered in the juxtacentromeric regions of several chromosomes, including chromosomes 9, 13, 18 and 21.
Similarity. Belongs to the BAGE family.
RefSeq proteins (0): (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR012530 | BAGE-like | Family |
Pfam: PF08180
UniProt features (2 total): signal peptide 1, chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q86Y27-F1 | 67.65 | 0.00 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 0 (showing top):
GO Biological Process (0):
GO Molecular Function (0):
GO Cellular Component (1): extracellular region (GO:0005576)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
0 interactions, top by confidence (×1000):
IntAct
2 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| ECE1 | BAGE5 | psi-mi:“MI:0915”(physical association) | 0.370 |
ESM2 similar proteins: A0A023PYH0, A8W7N3, B3EWI0, C0HJG6, C0HKQ2, C0HM37, C0HM38, D3VML5, P08230, P0ADD9, P0ADE0, P0ADE1, P0CU24, P0DJM5, P0DJP7, P0DJP8, P0DJP9, P0DJR2, P0DPM7, P14610, P26820, P33163, P39494, P40836, P43996, P55369, P55597, P55739, P59066, P64508, P64509, P64510, P64511, P80984, P81163, P81344, P82309, P82895, P83364, P83366
Diamond homologs: Q13072, Q86Y27, Q86Y28, Q86Y29, Q86Y30
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
0 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 0 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
0 predictions. Top by Δscore:
AlphaMissense
0 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS10450866 (13:18171925 C>G), RS1158550630 (13:18171802 A>C), RS1159824995 (13:18171505 G>A,T), RS1162862822 (13:18171375 C>A), RS1164634654 (13:18171780 T>C), RS1168181133 (13:18171607 T>G), RS1168591812 (13:18171979 G>C), RS1174076777 (13:18171866 G>A,T), RS1177688817 (13:18171467 T>C), RS1178138079 (13:18171717 G>A), RS1178589548 (13:18171898 C>G), RS1184520126 (13:18171699 A>G), RS1185418505 (13:18171388 TTC>T), RS1188686761 (13:18171619 A>G), RS1192343712 (13:18171905 C>T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
3 total (human), top 3 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | increases methylation | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
| Cadmium Chloride | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.